HT-3951 vs. Placebo in Stroke Rehabilitation

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Ischemic Stroke

In brief

This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation outcome measures, as well as fMRI techniques in a subset of subjects, to evaluate the effect of HT-3951 on motor recovery and behavior in medically stable subjects following ischemic stroke.

Key facts

Study ID

NCT02530307

Run by

Dart NeuroScience, LLC

People needed

61

Starts

2016-02-01

Expected to finish

2017-12-31

Last updated by the study team

2018-02-01

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Scottsdale, Arizona, United States
• Study site — Downey, California, United States
• Study site — Glendale, California, United States
• Study site — Loma Linda, California, United States
• Study site — Orlando, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Grand Rapids, Michigan, United States
• Study site — Kansas City, Missouri, United States
• Study site — West Orange, New Jersey, United States
• Study site — New York, New York, United States
• Study site — White Plains, New York, United States
• Study site — Charlotte, North Carolina, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Portland, Oregon, United States
• Study site — Elkins Park, Pennsylvania, United States
• Study site — Dallas, Texas, United States
• Study site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.